Logo image of OOMA

OOMA INC (OOMA) Stock Fundamental Analysis

NYSE:OOMA - New York Stock Exchange, Inc. - US6834161019 - Common Stock - Currency: USD

13.24  +0.06 (+0.46%)

After market: 13.24 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OOMA. OOMA was compared to 283 industry peers in the Software industry. While OOMA seems to be doing ok healthwise, there are quite some concerns on its profitability. OOMA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year OOMA was profitable.
In the past year OOMA had a positive cash flow from operations.
In the past 5 years OOMA always reported negative net income.
OOMA had a positive operating cash flow in each of the past 5 years.
OOMA Yearly Net Income VS EBIT VS OCF VS FCFOOMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

OOMA has a Return On Assets (-4.63%) which is comparable to the rest of the industry.
With a Return On Equity value of -8.09%, OOMA perfoms like the industry average, outperforming 54.06% of the companies in the same industry.
Industry RankSector Rank
ROA -4.63%
ROE -8.09%
ROIC N/A
ROA(3y)-2.66%
ROA(5y)-2.46%
ROE(3y)-5.01%
ROE(5y)-4.92%
ROIC(3y)N/A
ROIC(5y)N/A
OOMA Yearly ROA, ROE, ROICOOMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 60.74%, OOMA is in line with its industry, outperforming 41.34% of the companies in the same industry.
OOMA's Gross Margin has been stable in the last couple of years.
OOMA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y0.08%
OOMA Yearly Profit, Operating, Gross MarginsOOMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

5

2. Health

2.1 Basic Checks

OOMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OOMA has more shares outstanding
Compared to 5 years ago, OOMA has more shares outstanding
OOMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OOMA Yearly Shares OutstandingOOMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
OOMA Yearly Total Debt VS Total AssetsOOMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.70 indicates that OOMA is not in any danger for bankruptcy at the moment.
OOMA has a Altman-Z score of 3.70. This is in the better half of the industry: OOMA outperforms 64.31% of its industry peers.
OOMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.7
ROIC/WACCN/A
WACC9.81%
OOMA Yearly LT Debt VS Equity VS FCFOOMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

OOMA has a Current Ratio of 1.09. This is a normal value and indicates that OOMA is financially healthy and should not expect problems in meeting its short term obligations.
OOMA has a worse Current ratio (1.09) than 70.67% of its industry peers.
A Quick Ratio of 0.83 indicates that OOMA may have some problems paying its short term obligations.
OOMA has a Quick ratio of 0.83. This is amonst the worse of the industry: OOMA underperforms 80.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.83
OOMA Yearly Current Assets VS Current LiabilitesOOMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

6

3. Growth

3.1 Past

OOMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.36%, which is quite impressive.
The Earnings Per Share has been growing by 10.25% on average over the past years. This is quite good.
OOMA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.50%.
Measured over the past years, OOMA shows a quite strong growth in Revenue. The Revenue has been growing by 11.12% on average per year.
EPS 1Y (TTM)30.36%
EPS 3Y10.25%
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)8.5%
Revenue growth 3Y10.13%
Revenue growth 5Y11.12%
Sales Q2Q%4.05%

3.2 Future

Based on estimates for the next years, OOMA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.11% on average per year.
OOMA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.51% yearly.
EPS Next Y18.29%
EPS Next 2Y16.07%
EPS Next 3Y22.92%
EPS Next 5Y27.11%
Revenue Next Year4.45%
Revenue Next 2Y5.45%
Revenue Next 3Y5.34%
Revenue Next 5Y6.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OOMA Yearly Revenue VS EstimatesOOMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
OOMA Yearly EPS VS EstimatesOOMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.14, the valuation of OOMA can be described as rather expensive.
Based on the Price/Earnings ratio, OOMA is valued cheaply inside the industry as 82.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.52. OOMA is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 14.67, the valuation of OOMA can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OOMA indicates a rather cheap valuation: OOMA is cheaper than 83.39% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.25. OOMA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.14
Fwd PE 14.67
OOMA Price Earnings VS Forward Price EarningsOOMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

OOMA's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of OOMA indicates a rather cheap valuation: OOMA is cheaper than 85.51% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.1
EV/EBITDA 110.66
OOMA Per share dataOOMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OOMA's earnings are expected to grow with 22.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y16.07%
EPS Next 3Y22.92%

0

5. Dividend

5.1 Amount

No dividends for OOMA!.
Industry RankSector Rank
Dividend Yield N/A

OOMA INC

NYSE:OOMA (6/6/2025, 8:17:41 PM)

After market: 13.24 0 (0%)

13.24

+0.06 (+0.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)08-25 2025-08-25/amc
Inst Owners73.77%
Inst Owner Change3.61%
Ins Owners7.91%
Ins Owner Change15.26%
Market Cap364.89M
Analysts81.54
Price Target18.26 (37.92%)
Short Float %2.05%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.51%
Min EPS beat(2)7.43%
Max EPS beat(2)29.6%
EPS beat(4)4
Avg EPS beat(4)16.42%
Min EPS beat(4)7.43%
Max EPS beat(4)29.6%
EPS beat(8)6
Avg EPS beat(8)10.49%
EPS beat(12)10
Avg EPS beat(12)12.69%
EPS beat(16)14
Avg EPS beat(16)18.87%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)-0.73%
Revenue beat(4)1
Avg Revenue beat(4)-0.69%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.24%
Revenue beat(8)1
Avg Revenue beat(8)-1.31%
Revenue beat(12)2
Avg Revenue beat(12)-1.19%
Revenue beat(16)4
Avg Revenue beat(16)-0.9%
PT rev (1m)0%
PT rev (3m)2.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.3%
EPS NY rev (1m)0%
EPS NY rev (3m)11.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE 18.14
Fwd PE 14.67
P/S 1.42
P/FCF 18.1
P/OCF 13.71
P/B 4.28
P/tB 9.12
EV/EBITDA 110.66
EPS(TTM)0.73
EY5.51%
EPS(NY)0.9
Fwd EY6.82%
FCF(TTM)0.73
FCFY5.52%
OCF(TTM)0.97
OCFY7.29%
SpS9.32
BVpS3.09
TBVpS1.45
PEG (NY)0.99
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.63%
ROE -8.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.74%
FCFM 7.85%
ROA(3y)-2.66%
ROA(5y)-2.46%
ROE(3y)-5.01%
ROE(5y)-4.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y0.08%
F-Score5
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 64.08%
Cap/Sales 2.51%
Interest Coverage N/A
Cash Conversion 852.48%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.83
Altman-Z 3.7
F-Score5
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)75.59%
Cap/Depr(5y)79.48%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.36%
EPS 3Y10.25%
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y18.29%
EPS Next 2Y16.07%
EPS Next 3Y22.92%
EPS Next 5Y27.11%
Revenue 1Y (TTM)8.5%
Revenue growth 3Y10.13%
Revenue growth 5Y11.12%
Sales Q2Q%4.05%
Revenue Next Year4.45%
Revenue Next 2Y5.45%
Revenue Next 3Y5.34%
Revenue Next 5Y6.51%
EBIT growth 1Y-73.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.96%
EBIT Next 3Y32.93%
EBIT Next 5Y30.41%
FCF growth 1Y229.72%
FCF growth 3Y101.61%
FCF growth 5YN/A
OCF growth 1Y116.79%
OCF growth 3Y58.67%
OCF growth 5YN/A